2022---dr--martens-sieht-gewinnausf-lle-und-erh-ht-die-dividende-um-28-----magazin--gesundheits--und-sportnachrichten May 2026

The following metrics summarize the performance as of late 2022: £418.6 million +18% (11% CC) Direct-to-Consumer (DTC) Revenue Noted as a primary driver Profit Before Tax £57.9 million Under pressure from cost inflation EBITDA Margin -2.8 percentage points Interim Dividend 1.56p per share Analysis of the Report

: The report from Magazin Gesundheits- und Sportnachrichten highlighted these figures during a period of global economic uncertainty and a "challenging consumer backdrop". The following metrics summarize the performance as of

: The 28% dividend increase was a deliberate signal of management's "confidence in the future" despite the profit headwinds. This payout represented roughly 35% of earnings. In 2022, Dr

In 2022, Dr. Martens reported a mixed financial performance, characterized by alongside profitability pressures that led to a significant dividend increase . While the company achieved an 18% growth in underlying revenue during the first half of its financial year, it simultaneously faced "profit shortfalls" in the form of lower margins due to ongoing investments and a weakening economic environment. Key Financial Highlights (FY23 H1) Key Financial Highlights (FY23 H1) : Growth was

: Growth was balanced globally, though the Dr. Martens PLC Annual Report 2022 noted that "Originals" (classic boots like the 1460) remained the core revenue driver at 51%. bbc.com/news/articles/cm2kpwnr4rjo">BBC News ? DR. MARTENS PLC ANNUAL REPORT 2022

: Lower EBITDA margins were attributed to planned investments in new stores , marketing, and technology, as well as rising cost inflation which the company aimed to offset with price increases in 2023.